TR201009397A2 - Pharmaceutical compositions containing rosuvastatin. - Google Patents
Pharmaceutical compositions containing rosuvastatin.Info
- Publication number
- TR201009397A2 TR201009397A2 TR2010/09397A TR201009397A TR201009397A2 TR 201009397 A2 TR201009397 A2 TR 201009397A2 TR 2010/09397 A TR2010/09397 A TR 2010/09397A TR 201009397 A TR201009397 A TR 201009397A TR 201009397 A2 TR201009397 A2 TR 201009397A2
- Authority
- TR
- Turkey
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- containing rosuvastatin
- rosuvastatin
- particles
- Prior art date
Links
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 title abstract 2
- 229960000672 rosuvastatin Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000002245 particle Substances 0.000 abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 208000035150 Hypercholesterolemia Diseases 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000020346 hyperlipoproteinemia Diseases 0.000 abstract 1
- 208000006575 hypertriglyceridemia Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Mevcut buluş etken madde olarak rosuvastatin ve/veya farmasötik olarak kabul edilebilir bir tuzunu içeren farmasötik partiküller ve bu partiküllerin ateroskleroz, hiperkolesterolemi, hiperlipoproteinemi, hipertrigliseridemi, miyokard enfarktüsü tedavisi ve/veya önlenmesinde kullanılacak bir ilacın üretiminde kullanılması ile ilgilidir.The present invention relates to pharmaceutical particles comprising rosuvastatin as active ingredient and / or a pharmaceutically acceptable salt thereof, and to the use of such particles in the manufacture of a medicament for use in the treatment and / or prevention of atherosclerosis, hypercholesterolemia, hyperlipoproteinemia, hypertriglyceridemia, myocardial infarction.
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2010/09397A TR201009397A2 (en) | 2010-11-11 | 2010-11-11 | Pharmaceutical compositions containing rosuvastatin. |
| EP11725996A EP2566465A2 (en) | 2010-05-04 | 2011-05-03 | Stable rosuvastatin formulations |
| PCT/TR2011/000135 WO2011139256A2 (en) | 2010-05-04 | 2011-05-03 | Stable rosuvastatin formulations |
| PCT/TR2011/000249 WO2012064307A1 (en) | 2010-11-11 | 2011-11-03 | Pharmaceutical compositions comprising rosuvastatin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2010/09397A TR201009397A2 (en) | 2010-11-11 | 2010-11-11 | Pharmaceutical compositions containing rosuvastatin. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201009397A2 true TR201009397A2 (en) | 2012-05-21 |
Family
ID=45446165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2010/09397A TR201009397A2 (en) | 2010-05-04 | 2010-11-11 | Pharmaceutical compositions containing rosuvastatin. |
Country Status (2)
| Country | Link |
|---|---|
| TR (1) | TR201009397A2 (en) |
| WO (1) | WO2012064307A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR201009399A2 (en) * | 2010-11-11 | 2012-05-21 | Bi̇lgi̇ç Mahmut | Rapidly soluble effervescent rosuvastatin formulations. |
| US9763885B2 (en) | 2012-05-01 | 2017-09-19 | Althera Laboratories Ltd. | Oral tablet formulation consisting of fixed combination of rosuvastatin and ezetimibe for treatment of hyperlipidemia and cardiovascular diseases |
| US10376470B2 (en) | 2012-05-01 | 2019-08-13 | Althera Life Sciences, Llc | Oral tablet formulation consisting of fixed combination of rosuvastatin and ezetimibe for treatment of hyperlipidemia and cardiovascular diseases |
| EP2692354A1 (en) * | 2012-08-03 | 2014-02-05 | Max-Delbrück-Centrum für Molekulare Medizin (MDC) | Means for treating heart disease |
| KR20150079373A (en) | 2013-12-30 | 2015-07-08 | 한미약품 주식회사 | Composite formulation for oral administration comprising ezetimibe and rosuvastatin |
| US10413543B2 (en) | 2015-09-01 | 2019-09-17 | Sun Pharma Advanced Research Company Ltd. | Stable multiparticulate pharmaceutical composition of rosuvastatin |
| CZ2016539A3 (en) * | 2016-09-05 | 2018-03-14 | Zentiva, K.S. | A pharmaceutical composition comprising two different active substances and a method of its preparation |
| CZ2016538A3 (en) | 2016-09-05 | 2018-03-14 | Zentiva, K.S. | A pharmaceutical composition comprising two different active ingredients |
| CN108245516B (en) * | 2017-11-09 | 2019-04-12 | 浙江京新药业股份有限公司 | A kind of pharmaceutical composition and preparation method thereof containing rosuvastain calcium |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU9203780D0 (en) | 1991-12-12 | 1993-03-29 | Sandoz Ag | Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them |
| GB0001621D0 (en) | 2000-01-26 | 2000-03-15 | Astrazeneca Ab | Pharmaceutical compositions |
| EP2066644A2 (en) | 2006-08-04 | 2009-06-10 | Glenmark Pharmaceuticals Limited | Salts of rosuvastatin and processes for their preparation |
| EP2120882A2 (en) * | 2007-02-23 | 2009-11-25 | Krka | Pharmaceutical composition containing a cholesterol absorption inhibitor |
| WO2009024889A2 (en) | 2007-08-21 | 2009-02-26 | Ranbaxy Laboratories Limited | Pharmaceutical composition comprising a hmg-coa reductase inhibitor and ezetimibe |
| HRP20180077T1 (en) | 2008-06-27 | 2018-02-23 | Krka, Tovarna Zdravil D.D., Novo Mesto | PHARMACEUTICAL COMPOSITION CONTAINING STATIN |
| EP2216020A1 (en) * | 2009-02-05 | 2010-08-11 | KRKA, tovarna zdravil, d.d., Novo mesto | Moisture-activated granulation process |
| EP2566465A2 (en) * | 2010-05-04 | 2013-03-13 | Mahmut Bilgic | Stable rosuvastatin formulations |
-
2010
- 2010-11-11 TR TR2010/09397A patent/TR201009397A2/en unknown
-
2011
- 2011-11-03 WO PCT/TR2011/000249 patent/WO2012064307A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012064307A1 (en) | 2012-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR201009397A2 (en) | Pharmaceutical compositions containing rosuvastatin. | |
| IN2014MN01919A (en) | ||
| UA109010C2 (en) | MORPHOLINOPYRIMIDINES AND THEIR APPLICATIONS IN THERAPY | |
| EA201201050A1 (en) | PYRAZOLES AS AN ANTAGONISTS CRTH2 | |
| IN2013CN01340A (en) | ||
| UA113538C2 (en) | FLUOROMETHYL-5,6-DIHYDRO-4H- $ 1,3] OXAZINES | |
| MA44637B1 (en) | Heterocyclic compounds and their uses | |
| PH12015501156A1 (en) | Pharmaceutical compositions | |
| MX2015014083A (en) | Bace1 inhibitors. | |
| MX2016003754A (en) | A stable pharmaceutical composition containing amlodipine and valsartan. | |
| EA201291211A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING HYDROMORPHONE AND NALOXONE | |
| EA201300034A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING IMATINIB OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, AND WAYS TO OBTAIN THEM | |
| MX353061B (en) | Novel low concentration meloxicam tablets. | |
| PH12014502541A1 (en) | 5-amino [1,4] thiazines as bace 1 inhibitors | |
| PH12014502623A1 (en) | Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors | |
| EA201300857A1 (en) | PYRAZOLES AS AN ANTAGONISTS CRTH2 | |
| TR201001417A1 (en) | Cefdinir formulation with improved dissolution rate | |
| TN2016000207A1 (en) | Pharmaceutical dosage forms. | |
| MY160904A (en) | Piperazines as antimalarial agents | |
| TR201815617A2 (en) | A formulation containing dexketoprofen. | |
| TR201007926A1 (en) | Prasugrel tablet formulations. | |
| TR201005326A2 (en) | Multiple dosage forms. | |
| IN2014CN04119A (en) | ||
| TR201009399A2 (en) | Rapidly soluble effervescent rosuvastatin formulations. | |
| TR201005419A2 (en) | Pharmaceutical composition containing valsartan. |